Cypress Asset Management Inc. TX Invests $5.27 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Cypress Asset Management Inc. TX purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,004 shares of the healthcare conglomerate's stock, valued at approximately $5,267,000. UnitedHealth Group comprises about 1.6% of Cypress Asset Management Inc. TX's investment portfolio, making the stock its 21st largest holding.

Several other large investors have also recently bought and sold shares of the stock. SageView Advisory Group LLC boosted its position in UnitedHealth Group by 26.5% during the fourth quarter. SageView Advisory Group LLC now owns 10,973 shares of the healthcare conglomerate's stock valued at $5,526,000 after purchasing an additional 2,299 shares during the last quarter. BlackDiamond Wealth Management LLC lifted its position in shares of UnitedHealth Group by 31.7% in the fourth quarter. BlackDiamond Wealth Management LLC now owns 777 shares of the healthcare conglomerate's stock valued at $391,000 after buying an additional 187 shares during the last quarter. WBI Investments LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $2,015,000. Annis Gardner Whiting Capital Advisors LLC lifted its position in shares of UnitedHealth Group by 7.5% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 986 shares of the healthcare conglomerate's stock valued at $519,000 after buying an additional 69 shares during the last quarter. Finally, Frazier Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $353,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company's stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $4.52 during mid-day trading on Thursday, hitting $516.83. 2,854,708 shares of the stock traded hands, compared to its average volume of 4,184,481. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a market cap of $475.69 billion, a PE ratio of 31.59, a price-to-earnings-growth ratio of 1.52 and a beta of 0.55. The firm has a 50 day simple moving average of $488.88 and a two-hundred day simple moving average of $511.10.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the business posted $6.26 EPS. UnitedHealth Group's revenue for the quarter was up 8.6% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.46%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's payout ratio is presently 45.97%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on UNH shares. HSBC upgraded UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Cantor Fitzgerald reiterated an "overweight" rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Erste Group Bank reiterated a "hold" rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a research note on Monday, April 8th. Finally, Barclays raised their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.